However, P62/NRF2/HO-1 pathway is complex and rigorous, and a more rigorous experimental design is required to thoroughly investigate its mechanism in cancer, to provide a more theoretical basis for preventing and delaying the development of tumors, and provide new ideas for finding tumor treatment and the target of new drugs. This evidence concerns the gene SQSTM1 and cancer.